small molecule chemotherapeutic

Related by string. * smaller . Smaller . Smalls : Small Cap Index . Chris Smalling . Small Cap Value / Molecules . Molecule . molecules : small molecule therapeutics . small molecule inhibitor . stranded RNA molecules / Chemotherapeutic . chemotherapeutics : chemotherapeutic agents carboplatin . radioactive isotopes chemotherapeutics . RH1 targeted chemotherapeutic agent * *

Related by context. All words. (Click for frequent words.) 81 PDX pralatrexate 76 inhibits dihydrofolate reductase 75 RH1 72 hypoxia activated prodrug 72 non porcine pancreatic 71 oral Janus kinase 71 IMiDs R 71 targeted antifolate 71 2 methoxyestradiol 71 orally administered inhibitor 71 XL# anticancer compounds 70 novel immunomodulatory 70 Panzem R NCD 70 Panzem NCD 70 investigational humanized monoclonal antibody 70 Cloretazine ® 70 erlotinib Tarceva ® 69 potent topoisomerase II 69 peripherally acting 69 topoisomerase II inhibitor 69 treat chronic sinusitis 69 targeted radiotherapeutic 69 Alfacell proprietary ribonuclease 69 mTOR mammalian target 69 Panzem R 69 IAP inhibitor 69 oral immunomodulatory 69 liposomal formulation 69 HSP# inhibitor 69 oral anti arrhythmic 68 EGFr expressing metastatic colorectal 68 dasatinib Sprycel ® 68 PI3K/Akt pathway inhibitor 68 generation purine nucleoside 68 tumor vascular disrupting 68 cortisol synthesis 68 novel tubulin binding 68 Voreloxin 68 Cetrorelix pamoate 68 CDK inhibitor 68 topical gel formulation 68 MAGE A3 ASCI 68 Luteinizing Hormone Releasing Hormone 68 thalidomide Thalomid 68 MTP inhibitor 68 adenosine A2A 68 Cloretazine 68 mertansine 68 Romidepsin 68 AAG geldanamycin analog 68 non nucleoside inhibitor 68 receptor tyrosine kinase inhibitor 68 refractory chronic lymphocytic 68 intranasal formulation 67 selective kinase inhibitor 67 potent antiproliferative 67 Factor VIIa 67 polysaccharide polymer 67 factor VIIa 67 highly selective inhibitor 67 humanized anti 67 pan HDAC inhibitor 67 hypoxia selective 67 unique alkylating agent 67 generation Hsp# inhibitor 67 AKT inhibitor 67 Anidulafungin 67 Omacetaxine 67 IgG1 monoclonal antibody 67 small molecule glucokinase 67 Xanafide 67 pralatrexate injection folate analogue 67 vinca alkaloid 67 hyaluronidase enzyme 67 PNP inhibitor 67 acyclovir Lauriad R 67 bevacizumab Avastin R 67 candidate AQ4N 67 selective estrogen receptor modulator 67 pan histone deacetylase 67 PEGylated Fab fragment 67 novel emulsion formulation 67 somatostatin analogue 67 potent triglyceride lowering 67 class anticancer quinolone 67 lipoglycopeptide 67 mitogen activated ERK kinase 67 peptidic compound 67 oral antiviral 67 dasatinib Sprycel 67 R sorafenib tablets 67 substrates inhibitors 67 folate analogue metabolic 67 oral proteasome inhibitor 67 selective antagonist 67 vapreotide acetate 67 Darinaparsin 67 sodium glucose cotransporter 67 proteasome inhibitor 67 ALTROPANE R 67 selective A2A adenosine receptor 67 Aflibercept 67 Cloretazine R 67 Silodosin 67 Enzastaurin 67 long acting muscarinic 66 XL# XL# 66 selective serotonin 2C receptor 66 TNF Tumor Necrosis Factor 66 Pruvel TM 66 R lenalidomide 66 SinuNase ™ 66 accumulate preferentially 66 triggers apoptosis programmed 66 selectively inhibits 66 5 HT2A serotonin 66 PDE4 inhibitor 66 Annamycin 66 SinuNase TM 66 Daclizumab 66 Teriflunomide 66 semi synthetic lipoglycopeptide 66 IMiDs ® compound 66 secretory phospholipase A2 66 Phase #b/#a clinical 66 INSPIRE Trial Phase III 66 targeting CD# 66 histone deacetylase HDAC 66 anti secretory 66 oral prodrug 66 selective modulator 66 Hsp# Inhibitor 66 vinorelbine tartrate 66 Tumor necrosis factor 66 nilotinib Tasigna ® 66 topical antifungal 66 CYP#A# CYP#D# 66 Initiates Enrollment 66 oral isoform selective HDAC 66 targets Galectin receptors 66 Fc fusion protein 66 tubulin inhibitor 66 Pruvel ™ 66 LE SN# 66 VEGFR2 inhibitor 66 GW# [003] 66 peripherally restricted 66 IMiDs ® 66 plus prednisone prednisolone 66 candidate deforolimus 66 CA9 SCAN 66 Aurora Kinase 66 YONDELIS 66 antibody MAb 66 sorafenib tablets 66 cetuximab Erbitux R 66 MKC# MT 65 sunitinib Sutent ® 65 evaluating picoplatin 65 Orally administered 65 HCV RNA polymerase 65 refractory NSCLC 65 CG# [003] 65 poly ADP ribose polymerase 65 Pralatrexate 65 apoptosis inducer 65 DNA intercalator 65 huC# DM4 65 CYT# potent vascular disrupting 65 ENMD # 65 reversible inhibitor 65 #HT# 65 small molecule tyrosine 65 PSN# [001] 65 IL# PE#QQR 65 Carfilzomib 65 protein tyrosine phosphatase 1B 65 anti muscarinic 65 Pathway Inhibitor 65 insulin sensitizing 65 novel topoisomerase 65 developing Bicifadine serotonin 65 sapacitabine CYC# 65 dihydrofolate reductase 65 delta opioid receptor 65 anti atherothrombotic 65 histone deacetylase inhibitor 65 Epratuzumab 65 NEUGENE antisense 65 CYT# vascular disrupting 65 multi kinase inhibitor 65 Nexavar ® 65 novel histone deacetylase 65 PKC# 65 essential thrombocythemia ET 65 Pazopanib 65 RhuDex TM 65 nucleoside analog 65 CYC# 65 novel synthetic peptide 65 5 HT2A inverse 65 potent anticancer 65 antifibrotic 65 Xeloda ® 65 CD# monoclonal antibody 65 vinca alkaloids 65 HER1 65 Pharmacokinetics PK 65 selectively inhibited 65 epothilones 65 selective orally bioavailable 65 sorafenib Nexavar 65 cyclin dependent kinase inhibitor 65 VNP#M 65 proprietary polysaccharide 65 AEG# 65 vascular disrupting agents 65 LymphoStat B belimumab 65 oral antifungal 65 triciribine phosphate monohydrate 65 5 HT4 65 docetaxel Taxotere R 65 radiation sensitizer 65 liposome encapsulated 65 systemic antifungal 65 novel antifolate 65 developing Zerenex ferric 65 molecular imaging radiopharmaceutical 65 Elvitegravir 65 humanized monoclonal 65 LEVADEX TM 65 investigational antipsychotic 65 antifolates 65 Crofelemer budesonide foam 65 cytoprotective 65 selective adenosine 65 Epothilones 65 cathepsin K inhibitor 65 Darinaparsin Zinapar TM 64 ocular formulation 64 Phase Ib clinical trials 64 TRIOLEX HE# APOPTONE HE# 64 agent VDA 64 Zalypsis 64 Vidaza ® 64 Delta opioid receptor 64 Pegloticase 64 5 FU leucovorin 64 MKC# MKC# PP 64 Lenocta TM sodium stibogluconate 64 Oral NKTR 64 signal transduction inhibitor 64 taxane derivative 64 markets HP Acthar 64 Talabostat 64 selective inverse agonist 64 Ecallantide 64 allogeneic cell 64 bortezomib Velcade 64 novel anticancer 64 kidney urologic 64 immune modulator 64 Bosutinib 64 overactive bladder AA# 64 HepeX B TM 64 metformin sulfonylureas 64 non nucleoside 64 orally dosed 64 CYP#A# isoenzyme 64 multitargeted 64 IMPDH inhibitor 64 Vidaza azacitidine 64 GMX# 64 evaluating Xcytrin 64 TO AVOID PREGNANCY WHILE 64 Personalized Immunotherapy 64 CTAP# Injection 64 oral dihydropyrimidine dehydrogenase DPD 64 Bortezomib 64 chimeric monoclonal antibody 64 Serostim ® 64 R Saizen R 64 investigational pharmacologically unique 64 Zorbtive TM 64 Tesetaxel 64 IAP inhibitors 64 imatinib Gleevec ® 64 novel oral anticoagulant 64 inhibits Akt activation 64 antibiotic candidate Ramoplanin 64 FOLOTYN ® 64 personalized cellular immunotherapy 64 Sudhir Agrawal D.Phil 64 Cloretazine R VNP#M 64 histone deacetylase HDAC inhibitor 64 histamine dihydrochloride 64 Tyrima 64 PEGylated anti 64 tyrosine kinase inhibitor 64 pharmacologically active isomer 64 adenosine injection 64 atrial fibrillation budiodarone ATI 64 Initiate Clinical Trial 64 XP# XP# 64 humanised monoclonal antibody 64 Dalbavancin 64 BCG refractory carcinoma 64 potentially hepatotoxic 64 beta 1a 64 XL# XL# XL# 64 Aztreonam lysine 64 potent vascular disrupting 64 Elotuzumab 64 hormone LHRH antagonist 64 adrenoceptor 64 covalently linked 64 treat refractory angina 64 alvespimycin 64 TLK# 64 Perifosine 64 investigational molecular imaging 64 antibiofilm 64 Inhalation Powder 64 drug pipeline TAFA# 64 immune modulatory 64 FOLFOX6 chemotherapy regimen 64 TRX1 64 Auxilium transmucosal film 64 Romiplostim 64 GVAX ® 64 bevacizumab Avastin ® 64 R roscovitine CDK cyclin 64 microtubule inhibitor 64 isoform selective 64 immunomodulating 64 irreversible inhibitor 64 TLR9 agonist 64 TLR7 agonist 64 mocetinostat MGCD# 64 Bafetinib 64 personalized dendritic 64 antisense inhibitors 64 Liposomal 64 highly selective endothelin 64 Immunomodulatory 64 Dementia Related Psychosis 64 alkylating agent 64 subcutaneously administered 64 hypoxia inducible factor 64 sulfonylhydrazine class 64 cromolyn sodium 64 Squalamine 64 prodrugs 64 Telik logo TELINTRA 64 multikinase inhibitor 64 potent inducer 64 mTOR kinase 64 Cannabinor 64 HepDirect prodrug 64 RhuDex ® 64 erythropoietic 64 KRN# 64 miconazole Lauriad R 64 novel peptide 63 OvaRex R 63 SAR# [004] 63 adalimumab Humira 63 Peginterferon alfa 2b 63 TKB# 63 carbohydrate polymer 63 Liprotamase 63 NS#/#A protease 63 recurrent metastatic ovarian cancer 63 inhibitor PPI 63 Aplidin 63 Mg Uk 63 therefore therapeutically equivalent 63 immunotherapeutic agent 63 OMP #M# 63 TOCOSOL Camptothecin 63 BUPHENYL R 63 depsipeptide 63 thrombin component 63 oral ferric iron 63 injectable urethral bulking 63 Vidaza R 63 dependent kinase inhibitor 63 ® bortezomib 63 thrombin receptor 63 CB2 selective receptor agonist 63 Tezampanel 63 ATRA IV 63 xanthine oxidase inhibitor 63 rusalatide acetate 63 muscarinic receptor agonist 63 Leukine ® 63 Seliciclib 63 tubulin binding 63 Tubulin 63 pharmacokinetic interactions 63 Phase Ib II 63 PROSTASCINT R 63 5 fluorouracil leucovorin 63 small molecule Hedgehog 63 gemcitabine Gemzar ® 63 Archexin 63 psychiatric disorders ATI 63 orally inhaled 63 Initiates Phase II 63 calcitonin gene related 63 phase IIb clinical 63 Albuferon TM 63 THR beta agonist 63 Factor Receptor 63 HDACi 63 HCV protease 63 Bucindolol 63 telomerase therapeutic 63 injectable investigational 63 cysteamine bitartrate 63 Irinotecan 63 Completes Patient Enrollment 63 lexidronam injection 63 DNA methyltransferase inhibitors 63 Janus kinase 63 NS5B polymerase 63 MET VEGFR2 63 nucleoside reverse transcriptase inhibitor 63 Presents Preclinical Data 63 BAY #-# 63 ALK inhibitor 63 lintuzumab SGN 63 vesicular monoamine transporter 63 Preclinical studies suggest 63 Tarceva TM 63 topically applied SEPA 63 Anturol ® 63 selective immunoproteasome inhibitor 63 MEK inhibitors 63 irinotecan doxorubicin oxaliplatin paclitaxel 63 UPLYSO 63 topical ophthalmic 63 evaluating satraplatin 63 Meets Primary Endpoint 63 ELACYT 63 acetonide FA 63 antagonist LAMA 63 virus HCV protease inhibitor 63 Files IND 63 polyglutamate 63 FUSILEV enhances 63 Vinorelbine 63 oral anticancer 63 dextromethorphan quinidine 63 Iloperidone 63 oxazolidinone 63 patented Aganocide compounds 63 Blinatumomab 63 ADP receptor antagonist 63 docetaxel Taxotere ® 63 5 HT3 antagonist 63 intravesical infusion therapy 63 next generation URAT1 63 anti inflammatory NSAID 63 metaglidasen 63 humanized monoclonal antibody 63 Immunotherapeutic 63 cyclin dependent kinase CDK 63 inflammatory PDE 63 JAK inhibitor 63 ABL inhibitor 63 class mGluR5 inhibitor 63 rHuPH# recombinant human 63 monoclonal antibody IgG1 Mab 63 Cathepsin S 63 acadesine 63 visilizumab 63 methylnaltrexone bromide 63 selectively binds 63 sorafenib tablets small 63 Vitamin D analogue 63 CDK cyclin dependent 63 histone deacetylase HDAC inhibitors 63 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 63 acetylgalactosamine 6 63 novel DACH platinum 63 selective inhibition 63 SGLT 2 63 novel orally administered 63 radiotherapeutic 63 non nucleoside HCV 63 Onconase 63 vidofludimus 63 fludarabine phosphate 63 SPL# Gel vaginal microbicide 63 anionic backbone 63 generation proteasome inhibitor 63 alemtuzumab MS 63 alpha folate receptor 63 Cyclooxygenase Inhibiting Nitric Oxide 63 galiximab 63 oral talactoferrin 63 Cintredekin Besudotox 63 ara C 63 reslizumab 63 TELINTRA 63 Methylnaltrexone 63 Imatinib mesylate 63 Long acting beta2 63 intravenously administered 63 Mg Usa 63 phenylalanine ammonia lyase 63 PrevOnco 63 Annexin V 63 Cloretazine VNP#M 63 oral nucleoside analogue 62 Ofatumumab 62 RON Notch 62 NS5b 62 Maribavir 62 antimitotic 62 trastuzumab Herceptin R 62 2A receptor agonist 62 RenaZorb TM 62 gemcitabine Gemzar 62 combines paclitaxel 62 Tyrosine Kinase Inhibitor 62 sublingual tablet formulation 62 erlotinib Tarceva R 62 MVA HPV IL2 62 synthetic anti infective 62 Serostim R 62 Angiotensin Converting Enzyme 62 TAFA# 62 Curaxin 62 TRO# 62 Protein Kinase C 62 fosbretabulin 62 Kahalalide F 62 inhibit oxidative stress 62 Angiolix R 62 immunomodulatory 62 oxybutynin ATD TM 62 sunitinib malate 62 itraconazole Sporanox 62 cisplatin gemcitabine 62 Genasense ® 62 TRIOLEX ™ 62 MPS IVA 62 orally bioavailable 62 Myolimus 62 vascular disrupting agent 62 small molecule thrombopoietin 62 Novel Oral 62 cholesteryl ester transfer 62 Vicinium TM 62 metastatic malignant 62 capecitabine Xeloda R 62 selective inhibitor 62 Aliskiren 62 FEMALES SHOULD BE ADVISED 62 OMP #R# 62 p# inhibitor 62 Lenalidomide 62 Azacitidine 62 Leuprolide 62 aurora kinase 62 sorafenib Nexavar R 62 includes TOLAMBA TM 62 Cytarabine 62 lorvotuzumab mertansine 62 echinocandin 62 Vascular Disrupting Agent 62 investigational oral antiplatelet 62 pathophysiological effects 62 SPRYCEL ® 62 factor TNF 62 RH1 targeted chemotherapeutic agent 62 TELINTRA R 62 fluoropyrimidine 62 reversible inhibitors 62 anti amnesic 62 LEP ETU 62 candidates Azedra TM 62 novel VDA molecule 62 Augment TM 62 immunomodulatory properties 62 dopamine D2 62 delivers fluocinolone acetonide FA 62 Gel repository corticotropin injection 62 Indomethacin 62 topical non steroidal 62 candidate REP# 62 RAS MAPK pathway 62 mild vasodilator 62 orally absorbed 62 etanercept Enbrel 62 anticancer compound 62 ergot derivatives 62 evaluating tivozanib 62 reverse transcriptase inhibitors 62 camptothecin CPT 62 proteasome inhibitors 62 M# rationally 62 KSP inhibitor 62 inhaled formulation 62 heparanase 62 JAK2 inhibitors 62 enhance ApoA 62 brand ciclesonide HFA 62 gefitinib Iressa 62 pegylated 62 R roscovitine 62 investigational monoclonal antibody 62 Granulocyte Colony Stimulating Factor 62 biased ligand 62 treat hyperphosphatemia 62 JAK2 Inhibitor 62 Files Investigational 62 Medidur TM FA 62 Clolar ® 62 RNA antagonist 62 herpetic keratitis 62 alkylating 62 Eculizumab 62 Dapagliflozin 62 humanized therapeutic 62 busulfan 62 Tumor Necrosis Factor 62 oxidative stress inducer 62 Hedgehog Pathway Inhibitor 62 HCV NS3 protease 62 IMA# 62 Fludara ® 62 Solazed TM 62 humanized antibody 62 Ixabepilone 62 osteogenic 62 initiated Phase Ib 62 Cardium Therapeutics TM 62 demonstrated antitumor activity 62 Bezielle 62 mutational status 62 coronary stent merged 62 D aspartate NMDA receptor 62 oral Hsp# inhibitor 62 relapsed leukemia 62 monoclonal antibody conjugated 62 polymerase inhibitor 62 6 sulfatase 62 aripiprazole Abilify 62 ATL# [002] 62 Budesonide foam crofelemer 62 Eraxis 62 Fx #A 62 OAB overactive bladder 62 PSN# [002] 62 sapropterin dihydrochloride 62 oral ghrelin agonist 62 platform HDL Mimetic 62 antidiabetic 62 MCSP respectively 62 cytokine refractory 62 IMiD 62 MyVax R 62 prokinetic agent 62 Janus Kinase 62 #ME# 62 TRANSDUR ® 62 docetaxel Taxotere 62 Enzyme Replacement Therapy 62 EZN 62 phase III isavuconazole 62 HGS ETR2 62 Ad5FGF 4 62 Mipomersen 62 anti mitotic 62 nucleoside analogs 62 Phase 1b clinical trials 62 HMG CoA reductase inhibitors 62 #/#/# Cytokinetics Incorporated 62 Diffuse Large B 62 PROVENGE ® 62 PI3K/mTOR 62 proprietary intranasal insulin 62 Pemetrexed 62 cutaneous T 62 immunosuppressive compound 62 Sapacitabine 62 PXD# 62 Abiraterone acetate 62 interferon IFN 62 Ceflatonin R 62 Refractory Hodgkin Lymphoma 62 Nanobody 62 non peptidic protease 62 Lubiprostone 62 cediranib 62 Hsp# inhibitors 62 peptibody 62 apoptosis inducers 62 anticancer therapeutics 62 Akt inhibitor 62 aldehyde dehydrogenase ALDH2 deficiency 62 Luveris R Ovidrel R 62 mitotic kinesin 62 Glufosfamide 62 inhalation powder 61 alpha#beta# integrin 61 PPAR gamma agonist 61 Initiate Phase 61 antiangiogenic agent 61 progressive metastatic prostate 61 octreotide acetate 61 Aeolus Pharmaceuticals Announces 61 neratinib 61 interferon gamma 1b 61 CA4P 61 HGS ETR1 mapatumumab 61 Cytochrome P# 61 Anticalin R 61 Kuvan sapropterin dihydrochloride 61 Vaxfectin TM 61 pharmacodynamic properties 61 Therapeutic Competitors Companies 61 estramustine 61 triphendiol 61 CYP#A# substrate 61 HQK 61 rxRNA 61 Investigational Oral 61 microtubule targeting 61 4 PDE4 enzyme 61 BN# [002] 61 DP VPA 61 systemic anaplastic large 61 oral picoplatin 61 CEQ# 61 XL# XL# XL# XL# 61 CCR5 antagonist 61 PANVAC VF 61 apoptosis proteins 61 potent cytotoxic 61 AQD class 61 JAK2 inhibitor 61 certain protein tyrosine 61 Vascular Wrap TM 61 trastuzumab DM1 T DM1 61 novel prodrug 61 cisplatin carboplatin 61 Zemiva ™ 61 IMC A# 61 Transdrug R 61 compound perifosine 61 XOMA 3AB biodefense 61 TBC# 61 tests miRview TM 61 therapeutic monoclonal antibody 61 releasing hormone LHRH 61 gemtuzumab ozogamicin 61 small molecule modulators 61 ® lenalidomide 61 myelofibrosis polycythemia vera 61 HuMax TAC 61 Staphylococcus aureus Immune Globulin 61 4SC AG ISIN DE# 61 Degarelix 61 LAB CGRP 61 Initiates Clinical 61 ZOLINZA 61 5 FU capecitabine 61 N acetylgalactosamine 6 61 immune modulating 61 compound PMX # 61 PEGylated interferon 61 Serdaxin ® 61 aflibercept VEGF Trap 61 Afatinib 61 Plecanatide 61 Initiates Clinical Trial 61 NPC 1C 61 MEK inhibitor 61 radiolabeled 61 benign prostatic hypertrophy BPH 61 Exherin 61 selective androgen receptor modulator 61 Aclidinium bromide 61 novel synthetic PEGylated 61 pancreatic enzyme replacement 61 memantine HCl 61 sargramostim 61 anticancer activity 61 antineoplastic 61 Sevelamer 61 Apixaban 61 Familial Adenomatous Polyposis FAP 61 factor Xa inhibitor 61 DCVax R 61 norepinephrine reuptake inhibitor 61 chemically modified tetracyclines 61 telomerase inhibitor drug 61 bucindolol hydrochloride 61 Etoposide 61 peptidomimetic 61 RTP #i 61 PEG SN# 61 tramiprosate Alzhemed TM 61 topical antimicrobial 61 kinase inhibition 61 MOVIPREP R 61 Anticalins ® 61 Elesclomol 61 Disease IBD 61 Akt activation 61 systemically administered 61 Adenoscan R 61 ceftazidime 61 Anticalins R 61 integrin inhibitor 61 using VIAdel TM 61 dihydrofolate reductase DHFR 61 injectable formulation 61 VEGF inhibitors 61 L Annamycin 61 fibrotic disease 61 defensin mimetic antibiotic 61 M2 subunit 61 blood clot dissolving 61 BCR ABL inhibitors 61 Factor VEGF 61 stable nucleic acid 61 polymerase inhibitors 61 Zemiva TM 61 converting enzyme 61 Ocrelizumab 61 thiazolidinedione TZD 61 prescribed proton pump 61 B lymphocyte stimulator 61 Monoclonal 61 octreotide implant 61 Pegylated 61 Iluvien TM 61 basal insulin analogue 61 mesylate 61 NEBIDO R 61 CRMD# 61 Interferon gamma 61 Ovitrelle R Serostim 61 HGS# 61 corticotropin injection 61 SUTENT ® 61 Interferon alpha 61 Tumour Vascular Disrupting Agent 61 Ambrisentan 61 hypereosinophilic syndrome 61 Biolimus A9 61 polyclonal antibody 61 5 HT2A receptor 61 Triapine R 61 Kinase Inhibitor 61 Locked Nucleic Acid 61 uricase 61 potent inhibitor 61 tiapamil 61 Kamada AAT 61 thymidylate synthase TS 61 GLPG# 61 potently inhibit 61 GRNOPC1 contains 61 preferentially bind 61 cetuximab Erbitux ® 61 IV Busulfex 61 SURFAXIN r 61 markets COLAZAL 61 partial agonist 61 neuropathy sparing 61 Muraglitazar 61 alpha TNFa 61 DOS# 61 mTOR inhibitor 61 Helixate R 61 microsomal triglyceride transfer 61 product platforms AZX# 61 investigational oral inhibitor 61 Tesamorelin 61 seliciclib CYC# 61 5 HT2C 61 Trofex ™ 61 tetrasodium 61 VAPRISOL 61 product candidate Lpathomab 61 rhIGF-I/rhIGFBP-3 61 directed radiotherapeutic antibody 61 fluoroquinolone class 61 nilotinib Tasigna 61 interferon alpha IFN 61 Xcytrin R 61 monoclonal antibody MAb 61 modulator SERM 61 Cyclooxygenase 61 ABLYNX 61 immunomodulator 61 diarrhea predominant irritable 61 Spiegelmer ® 61 Kosan proprietary 61 TRACON Pharmaceuticals 61 Teysuno 61 inhibit angiogenesis 61 Resten NG 61 targets HGF FGFR 61 sodium glucose transporter 61 Adenosine A2A 61 HCV NS5B polymerase 61 mineralocorticoid 61 LymphoStat B TM 61 CTAP# Capsules 61 nanofiltered plasma derived 61 NeuroSTAT ® 61 Advancing Drugs 61 GEM OS2 61 Zenvia ™ 61 leading oral taxane 61 treat male hypogonadism 61 DiLA2 61 TRISENOX ® 61 RhuDex R 61 MediGene focuses 61 subcutaneous formulation 61 myelodysplastic myeloproliferative diseases 61 intravesical instillation 61 Rebif ® 61 Pegasys ® 61 Cleviprex TM clevidipine 61 Trabectedin 61 small molecule activator 61 CCR9 antagonist 61 PORxin TM 61 Epidermal Growth Factor Receptor 61 SYN# 61 Calcitonin 61 selective phosphodiesterase 61 R metformin Concor 61 arsenic trioxide injection 61 PEG interferon 61 occlusion PAO 61 Entereg R 61 Fluticasone 61 PEP# [003] 61 Pradefovir 61 carmustine 61 EGFR HER2 61 adecatumumab MT# 61 Emergent marketed 61 Oxytrex TM 61 investigational pan BCR 61 engineered proteases 61 substantially excreted 61 sorafenib Nexavar ® 61 S1P antibody 61 mTOR inhibitors 61 ganetespib 61 Vascular Endothelial Growth 61 Retinoic Acid 61 agonistic human 61 antiresorptive 61 COPEGUS R 61 PARP inhibitor 61 abatacept Orencia 61 phosphoinositide 3 61 hepatotoxic 61 6R BH4 61 Varespladib 61 proprietary HuCNS SC 61 Troxatyl 61 Mycophenolate Mofetil 60 modified glutathione analog 60 sulindac 60 epothilone 60 Exelixis compounds 60 Ganciclovir 60 amrubicin 60 neuronal nicotinic receptor NNR 60 Anti Tumor 60 COPREXA ™ 60 ZEVALIN ® 60 Inhalation Solution 60 candidate iSONEP TM 60 Pyridorin 60 Genz # 60 CLORETAZINE TM VNP#M 60 ZK EPO 60 Recombinant Human 60 G Protein Coupled 60 factor HGF 60 glycopeptide 60 retaspimycin hydrochloride 60 melphalan prednisone 60 HCV polymerase 60 Successfully Completes Phase

Back to home page